Instituto Massone Overview
- Year Founded
-
1930
- Status
-
Acquired/Merged
- Employees
-
350
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Instituto Massone General Information
Description
Developer of naturally occurring gonadotropins intended for treatments against female and male infertility. The company provides ongoing research and development services for potentially useful drugs for the treatment of different pathologies, thereby enabling medical companies to meet the requirements of the different world pharmacopeias.
Contact Information
Website
www.massone.com(Operating Subsidiary)
Corporate Office
- Arias 4431
- Buenos Aires, C1430CSE
- Argentina
Corporate Office
- Arias 4431
- Buenos Aires, C1430CSE
- Argentina
Instituto Massone Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Instituto Massone Patents
Instituto Massone Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3397258-A2 | Use of brassinosteroid analogs for the treatment of dermal disorders by selectively modulating liver x receptors (lxr) and dermal disease treatment by brassinosteroid analogs acting as selective liver x receptor (lxr) modulators | Inactive | 30-Dec-2015 | ||
| US-20190365784-A1 | Use of brassinosteroid analogs for the treatment of dermal disorders by selectively modulating liver x receptors (lxr) and dermal disease treatment by brassinosteroid analogs acting as selective liver x receptor (lxr) modulators | Inactive | 30-Dec-2015 | ||
| WO-2017115319-A2 | Use of brassinosteroid analogs for the treatment of dermal disorders by selectively modulating liver x receptors (lxr) and dermal disease treatment by brassinosteroid analogs acting as selective liver x receptor (lxr) modulators | Inactive | 30-Dec-2015 | ||
| WO-2017115319-A3 | Use of brassinosteroid analogs for the treatment of dermal disorders by selectively modulating liver x receptors (lxr) and dermal disease treatment by brassinosteroid analogs acting as selective liver x receptor (lxr) modulators | Inactive | 30-Dec-2015 | ||
| EP-3145950-A1 | A process for obtaining hmg-up (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants | Active | 23-May-2014 | C07K14/59 |
Instituto Massone Signals
Instituto Massone FAQs
-
When was Instituto Massone founded?
Instituto Massone was founded in 1930.
-
Where is Instituto Massone headquartered?
Instituto Massone is headquartered in Buenos Aires, Argentina.
-
What is the size of Instituto Massone?
Instituto Massone has 350 total employees.
-
What industry is Instituto Massone in?
Instituto Massone’s primary industry is Pharmaceuticals.
-
Is Instituto Massone a private or public company?
Instituto Massone is a Private company.
-
What is the current valuation of Instituto Massone?
The current valuation of Instituto Massone is .
-
What is Instituto Massone’s current revenue?
The current revenue for Instituto Massone is .
-
When was Instituto Massone acquired?
Instituto Massone was acquired on 15-Feb-2023.
-
Who acquired Instituto Massone?
Instituto Massone was acquired by Ferring.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process